ArticleJAMA network open2021
Ruxolitinib for the Treatment of Steroid-Refractory Chronic Graft-vs-Host Disease-Another Hopeful Step Forward.
Joseph Clemente AlvarnasPubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this paperpooled itcites it